发明授权
US08148385B2 Substituted [1,2,3] triazolo[4,5-d]pyrimidine derivatives as ADP P2Y12 receptor antagonists
有权
取代的[1,2,3]三唑并[4,5-d]嘧啶衍生物作为ADP P2Y12受体拮抗剂
![Substituted [1,2,3] triazolo[4,5-d]pyrimidine derivatives as ADP P2Y12 receptor antagonists](/docs/US/2012-04-03/US08148385B2/abs.jpg.600x600.jpg)
- 专利标题： Substituted [1,2,3] triazolo[4,5-d]pyrimidine derivatives as ADP P2Y12 receptor antagonists
- 专利标题（中）： 取代的[1,2,3]三唑并[4,5-d]嘧啶衍生物作为ADP P2Y12受体拮抗剂
-
申请号： US11980907申请日： 2007-10-31
-
公开(公告)号： US08148385B2公开(公告)日： 2012-04-03
- 发明人: Han-Cheng Zhang , Bruce E. Maryanoff , Hong Ye , Cailin Chen
- 申请人： Han-Cheng Zhang , Bruce E. Maryanoff , Hong Ye , Cailin Chen
- 申请人地址： BE
- 专利权人： Janssen Pharmaceutica N.V.
- 当前专利权人： Janssen Pharmaceutica N.V.
- 当前专利权人地址： BE
- 代理商 Yuriy P. Stercho
- 主分类号： C07D487/04
- IPC分类号： C07D487/04 ; A61K31/519 ; A61P7/02 ; A61P9/10 ; A61P37/06 ; A61P25/06
![Substituted [1,2,3] triazolo[4,5-d]pyrimidine derivatives as ADP P2Y12 receptor antagonists](/abs-image/US/2012/04/03/US08148385B2/abs.jpg.150x150.jpg)
摘要：
The present invention is directed to novel bicyclic triazolopyrimidine compounds of Formula (I) or a form thereof: wherein X1, X2, R1, R2, R3 and R4 are as defined herein, and their methods of preparation and use as ADP inhibitors.
公开/授权文献
信息查询
